General Information of Drug Transporter (DT)
DT ID DTD0338 Transporter Info
Gene Name SLC39A10
Transporter Name Zinc transporter ZIP10
Gene ID
57181
UniProt ID
Q9ULF5

Transcriptional Regulation of This DT (TSR)

TF Superclass1: Basic domains

      Class1.1: Basic leucine zipper factors

Click to Show/Hide the Full List of 8 TF(s) Regulating This DT

        ATF2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [1]

TF Protein Name

Cyclic AMP-dependent transcription factor ATF-2 Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Cyclic AMP-dependent transcription factor ATF-2 (ATF2) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        CEBPA 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [2]

TF Protein Name

CCAAT/enhancer-binding protein alpha Transcription Factor Info

Tissue

Blood; Liver

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

CCAAT/enhancer-binding protein alpha (CEBPA) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        CEBPB 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [3]

TF Protein Name

CCAAT/enhancer-binding protein beta Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        CREB1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [4]

TF Protein Name

Cyclic AMP-responsive element-binding protein 1 Transcription Factor Info

Tissue

Blood; Liver

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        FOS 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [1]

TF Protein Name

Protein c-Fos Transcription Factor Info

Tissue

Bone marrow; Breast; Cervix; Vein

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Protein c-Fos (FOS) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        FOSL2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [2]

TF Protein Name

Fos-related antigen 2 Transcription Factor Info

Tissue

Brain; Breast; Liver; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Fos-related antigen 2 (FOSL2) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        JUN 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC39A10 gene in K562 cells [5]

TF Protein Name

Transcription factor Jun Transcription Factor Info

Related DT Changes

Direct regulating

Detailed Description

Transcription factor Jun (JUN) has been reported to bind to the transcription of SLC39A10 gene in K562 cells, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10.

        JUND 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [2]

TF Protein Name

Transcription factor JunD Transcription Factor Info

Tissue

Bone marrow; Brain; Cervix; Colon; Coronary artery; Embryo; Liver; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor JunD (JUND) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

      Class1.2: Basic helix-loop-helix factors

Click to Show/Hide the Full List of 6 TF(s) Regulating This DT

        MYC 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Repression of SLC39A10 gene in medulloblastoma condition [6]

TF Protein Name

Myc proto-oncogene protein Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Down regulating

Detailed Description

Myc proto-oncogene protein (MYC) has been reported to repress the transcription of SLC39A10 gene in medulloblastoma condition, which leads to a decreased expression of the drug transporter Zrt- and Irt-like protein 10.

        TCF12 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [3]

TF Protein Name

Transcription factor 12 Transcription Factor Info

Tissue

Blood; Brain; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor 12 (TCF12) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        TCF3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [4]

TF Protein Name

Transcription factor E2-alpha Transcription Factor Info

Tissue

Blood; Bone marrow

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor E2-alpha (TCF3) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        TCF4 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC39A10 gene in colorectal cancer condition [7]

TF Protein Name

Transcription factor 4 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Transcription factor 4 (TCF4) has been reported to activate the transcription of SLC39A10 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 10.

        USF1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [3]

TF Protein Name

Upstream stimulatory factor 1 Transcription Factor Info

Tissue

Brain; Colon; Liver; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Upstream stimulatory factor 1 (USF1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        USF2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [4]

TF Protein Name

Upstream stimulatory factor 2 Transcription Factor Info

Tissue

Blood; Cervix; Embryo

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Upstream stimulatory factor 2 (USF2) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

      Class1.3: Basic helix-span-helix factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        TFAP2A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [4]

TF Protein Name

Transcription factor AP-2-alpha Transcription Factor Info

Tissue

Breast; Cervix

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor AP-2-alpha (TFAP2A) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        TFAP2C 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [1]

TF Protein Name

Transcription factor AP-2 gamma Transcription Factor Info

Tissue

Breast; Cervix; Skin

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

TF Superclass2: Zinc-coordinating DNA-binding domains

      Class2.1: Nuclear receptors with C4 zinc fingers

Click to Show/Hide the Full List of 5 TF(s) Regulating This DT

        AR 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC39A10 gene in prostate cancer condition [8]

TF Protein Name

Androgen receptor Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Androgen receptor (AR) has been reported to activate the transcription of SLC39A10 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 10.

       Transcriptional Phenomenon2

Binding to SLC39A10 gene in prostate cancer condition [9]

TF Protein Name

Androgen receptor Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Androgen receptor (AR) has been reported to bind to the transcription of SLC39A10 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10.

        ESR1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [2]

TF Protein Name

Estrogen receptor Transcription Factor Info

Tissue

Breast

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Estrogen receptor (ESR1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        NR3C1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC39A10 gene in ER(-) breast cancer condition [10]

TF Protein Name

Glucocorticoid receptor Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Glucocorticoid receptor (NR3C1) has been reported to activate the transcription of SLC39A10 gene in ER(-) breast cancer condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 10.

        PGR 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [1]

TF Protein Name

Progesterone receptor Transcription Factor Info

Tissue

Breast

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Progesterone receptor (PGR) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        VDR 

Click to Show/Hide to Show 3 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC39A10 gene in THP-1 human monocytic leukemia cells condition [11]

TF Protein Name

Vitamin D3 receptor Transcription Factor Info

Affected Drug/Substrate

1,25-dihydroxyvitamin D3

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Vitamin D3 receptor (VDR) has been reported to activate the transcription of SLC39A10 gene in THP-1 human monocytic leukemia cells condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 10.

       Transcriptional Phenomenon2

Binding to SLC39A10 gene in health condition [12]

TF Protein Name

Vitamin D3 receptor Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Vitamin D3 receptor (VDR) has been reported to bind to the transcription of SLC39A10 gene in health condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10.

       Transcriptional Phenomenon3

Binding to SLC39A10 gene in THP-1 human monocytic leukemia cells condition [13]

TF Protein Name

Vitamin D3 receptor Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Vitamin D3 receptor (VDR) has been reported to bind to the transcription of SLC39A10 gene in THP-1 human monocytic leukemia cells condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10.

      Class2.2: Other C4 zinc finger-type factors

Click to Show/Hide the Full List of 4 TF(s) Regulating This DT

        GATA1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [3]

TF Protein Name

Erythroid transcription factor Transcription Factor Info

Tissue

Blood; Bone marrow

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Erythroid transcription factor (GATA1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        GATA2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC39A10 gene in hematopoiesis condition [14]

TF Protein Name

Endothelial transcription factor GATA-2 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Endothelial transcription factor GATA-2 (GATA2) has been reported to bind to the transcription of SLC39A10 gene in hematopoiesis condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10.

        GATA3 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC39A10 gene in breast cancer condition [15]

TF Protein Name

Trans-acting T-cell-specific transcription factor GATA-3 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) has been reported to bind to the transcription of SLC39A10 gene in breast cancer condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10.

       Transcriptional Phenomenon2

Direct binding to SLC39A10 gene [4]

TF Protein Name

Trans-acting T-cell-specific transcription factor GATA-3 Transcription Factor Info

Tissue

Blood; Brain; Breast; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        GATA4 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [1]

TF Protein Name

Transcription factor GATA-4 Transcription Factor Info

Tissue

Heart

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor GATA-4 (GATA4) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

      Class2.3: C2H2 zinc finger factors

Click to Show/Hide the Full List of 10 TF(s) Regulating This DT

        BCL11A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [2]

TF Protein Name

B-cell lymphoma/leukemia 11A Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

B-cell lymphoma/leukemia 11A (BCL11A) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        BCL6 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [3]

TF Protein Name

B-cell lymphoma 6 protein Transcription Factor Info

Tissue

Blood; Bone marrow; Tonsil

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

B-cell lymphoma 6 protein (BCL6) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        CTCF 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [4]

TF Protein Name

Transcriptional repressor CTCF Transcription Factor Info

Tissue

Brain

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcriptional repressor CTCF (CTCF) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        EGR1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [1]

TF Protein Name

Early growth response protein 1 Transcription Factor Info

Tissue

Bone marrow; Colon

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Early growth response protein 1 (EGR1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        KLF1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [2]

TF Protein Name

Krueppel-like factor 1 Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Krueppel-like factor 1 (KLF1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        KLF4 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [3]

TF Protein Name

Krueppel-like factor 4 Transcription Factor Info

Tissue

Foreskin; Pancreatic ductal; Skin

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Krueppel-like factor 4 (KLF4) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        KLF9 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [4]

TF Protein Name

Krueppel-like factor 9 Transcription Factor Info

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Krueppel-like factor 9 (KLF9) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        MAZ 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [4]

TF Protein Name

Myc-associated zinc finger protein Transcription Factor Info

Tissue

Blood; Bone marrow; Cervix; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Myc-associated zinc finger protein (MAZ) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        MECOM 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [1]

TF Protein Name

Histone-lysine N-methyltransferase MECOM Transcription Factor Info

Tissue

Colon

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Histone-lysine N-methyltransferase MECOM (MECOM) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        MTF1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Repression of SLC39A10 gene in health condition [16]

TF Protein Name

Metal regulatory transcription factor 1 Transcription Factor Info

Affected Drug/Substrate

Zinc

Studied Phenotype

Heallth [ICD11: N.A]

Tissue

Embryo

Related DT Changes

Down regulating

Experimental Material

Mtf1 KO mice

Detailed Description

Metal regulatory transcription factor 1 (MTF1) has been reported to repress the transcription of SLC39A10 gene in health condition, which leads to a decreased expression of the drug transporter Zrt- and Irt-like protein 10.

TF Superclass3: Helix-turn-helix domains

      Class3.1: Homeo domain factors

Click to Show/Hide the Full List of 3 TF(s) Regulating This DT

        HOXA1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [3]

TF Protein Name

Homeobox protein Hox-A1 Transcription Factor Info

Tissue

Colon

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Homeobox protein Hox-A1 (HOXA1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        NKX2-1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [2]

TF Protein Name

Homeobox protein Nkx-2.1 Transcription Factor Info

Tissue

Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Homeobox protein Nkx-2.1 (NKX2-1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        PBX3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [3]

TF Protein Name

Pre-B-cell leukemia transcription factor 3 Transcription Factor Info

Tissue

Brain; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Pre-B-cell leukemia transcription factor 3 (PBX3) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

      Class3.3: Fork head / winged helix factors

Click to Show/Hide the Full List of 4 TF(s) Regulating This DT

        E2F6 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [3]

TF Protein Name

Transcription factor E2F6 Transcription Factor Info

Tissue

Bone marrow; Embryo; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor E2F6 (E2F6) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        FOXA1 

Click to Show/Hide to Show 3 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC39A10 gene in prostate carcinoma condition [17]

TF Protein Name

Hepatocyte nuclear factor 3-alpha Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Hepatocyte nuclear factor 3-alpha (FOXA1) has been reported to bind to the transcription of SLC39A10 gene in prostate carcinoma condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10.

       Transcriptional Phenomenon2

Binding to SLC39A10 gene in prostate cancer condition [8]

TF Protein Name

Hepatocyte nuclear factor 3-alpha Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Hepatocyte nuclear factor 3-alpha (FOXA1) has been reported to bind to the transcription of SLC39A10 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10.

       Transcriptional Phenomenon3

Direct binding to SLC39A10 gene [1]

TF Protein Name

Hepatocyte nuclear factor 3-alpha Transcription Factor Info

Tissue

Breast; Embryo; Liver; Lung; Pancreatic ductal; Prostate; Uterus

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        FOXA2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [2]

TF Protein Name

Hepatocyte nuclear factor 3-beta Transcription Factor Info

Tissue

Colon

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        FOXP1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [1]

TF Protein Name

Forkhead box protein P1 Transcription Factor Info

Tissue

Embryo; Prostate

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Forkhead box protein P1 (FOXP1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

      Class3.5: Tryptophan cluster factors

Click to Show/Hide the Full List of 7 TF(s) Regulating This DT

        ELK3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC39A10 gene in hypoxia condition [18]

TF Protein Name

ETS domain-containing protein Elk-3 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

ETS domain-containing protein Elk-3 (ELK3) has been reported to bind to the transcription of SLC39A10 gene in hypoxia condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10.

        ETS1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [4]

TF Protein Name

Protein C-ets-1 Transcription Factor Info

Tissue

Blood; Bone; Bone marrow; Kidney; Lung; Prostate; Vein

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Protein C-ets-1 (ETS1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        FLI1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [4]

TF Protein Name

Friend leukemia integration 1 transcription factor Transcription Factor Info

Tissue

Blood; Mesenchymal; Vein

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        GABPA 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [2]

TF Protein Name

GA-binding protein alpha chain Transcription Factor Info

Tissue

Blood; Liver

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

GA-binding protein alpha chain (GABPA) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        IRF1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [3]

TF Protein Name

Interferon regulatory factor 1 Transcription Factor Info

Tissue

Blood; Bone marrow; Pancreatic ductal

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Interferon regulatory factor 1 (IRF1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        IRF4 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [4]

TF Protein Name

Interferon regulatory factor 4 Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Interferon regulatory factor 4 (IRF4) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        SPI1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [4]

TF Protein Name

Transcription factor PU.1 Transcription Factor Info

Tissue

Adrenal gland; Blood; Bone marrow; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor PU.1 (SPI1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

      Class3.7: ARID domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        KDM5B 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [1]

TF Protein Name

Lysine-specific demethylase 5B Transcription Factor Info

Tissue

Bone marrow; Breast

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Lysine-specific demethylase 5B (KDM5B) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

TF Superclass4: Other all-alpha-helical DNA-binding domains

      Class4.2: Heteromeric CCAAT-binding factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        NFYA 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [2]

TF Protein Name

Nuclear transcription factor Y subunit alpha Transcription Factor Info

Tissue

Colon

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Nuclear transcription factor Y subunit alpha (NFYA) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

TF Superclass5: alpha-Helices exposed by beta-structures

      Class5.1: MADS box factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        MEF2A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [3]

TF Protein Name

Myocyte-specific enhancer factor 2A Transcription Factor Info

Tissue

Bone marrow; Brain

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Myocyte-specific enhancer factor 2A (MEF2A) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

TF Superclass6: Immunoglobulin fold

      Class6.1: Rel homology region factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        RELA 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC39A10 gene in fibrosarcoma condition [19]

TF Protein Name

Transcription factor p65 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Transcription factor p65 (RELA) has been reported to activate the transcription of SLC39A10 gene in fibrosarcoma condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 10.

      Class6.2: STAT domain factors

Click to Show/Hide the Full List of 3 TF(s) Regulating This DT

        STAT3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC39A10 gene in glioblastoma multiforme condition [20]

TF Protein Name

Signal transducer and activator of transcription 3 Transcription Factor Info

Affected Drug/Substrate

Temozolomide

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Signal transducer and activator of transcription 3 (STAT3) has been reported to bind to the transcription of SLC39A10 gene in glioblastoma multiforme condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10.

        STAT5A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [2]

TF Protein Name

Signal transducer and activator of transcription 5A Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Signal transducer and activator of transcription 5A (STAT5A) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        STAT5B 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [1]

TF Protein Name

Signal transducer and activator of transcription 5B Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Signal transducer and activator of transcription 5B (STAT5B) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

      Class6.3: p53 domain factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        TP63 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC39A10 gene in epithelial to mesenchymal transition condition [21]

TF Protein Name

Tumor protein 63 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC39A10 gene in epithelial to mesenchymal transition condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10.

       Transcriptional Phenomenon2

Binding to SLC39A10 gene in health condition [22]

TF Protein Name

Tumor protein 63 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC39A10 gene in health condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10.

        TP73 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [1]

TF Protein Name

Tumor protein p73 Transcription Factor Info

Tissue

Skin

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Tumor protein p73 (TP73) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

      Class6.4: Runt domain factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        RUNX2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC39A10 gene in prostate cancer condition [23]

TF Protein Name

Runt-related transcription factor 2 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Runt-related transcription factor 2 (RUNX2) has been reported to activate the transcription of SLC39A10 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Zrt- and Irt-like protein 10.

        RUNX3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [4]

TF Protein Name

Runt-related transcription factor 3 Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Runt-related transcription factor 3 (RUNX3) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

      Class6.7: Grainyhead domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        GRHL2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [3]

TF Protein Name

Grainyhead-like protein 2 homolog Transcription Factor Info

Tissue

Breast; Bronchus

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold

      Class7.1: SMAD/NF-1 DNA-binding domain factors

Click to Show/Hide the Full List of 3 TF(s) Regulating This DT

        NFIC 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [2]

TF Protein Name

Nuclear factor 1 C-type Transcription Factor Info

Tissue

Blood; Brain; Liver; Uterus

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Nuclear factor 1 C-type (NFIC) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        SMAD3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [1]

TF Protein Name

Mothers against decapentaplegic homolog 3 Transcription Factor Info

Tissue

Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Mothers against decapentaplegic homolog 3 (SMAD3) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.

        SMAD4 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC39A10 gene in epithelial ovarian cancer condition [24]

TF Protein Name

Mothers against decapentaplegic homolog 4 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to bind to the transcription of SLC39A10 gene in epithelial ovarian cancer condition, which leads to an affected expression of the drug transporter Zrt- and Irt-like protein 10.

TF Superclass10: Yet undefined DNA-binding domains

      Class10.1: Other factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        SETDB1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC39A10 gene [3]

TF Protein Name

Histone-lysine N-methyltransferase SETDB1 Transcription Factor Info

Tissue

Bone

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Histone-lysine N-methyltransferase SETDB1 (SETDB1) can directly bind to the SLC39A10 gene, which in turn affects the expression or function of the drug transporter Zrt- and Irt-like protein 10.
References
1 Closure of the NCBI SRA and implications for the long-term future of genomics data storage. Genome Biol. 2011;12(3):402.
2 The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
3 hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020 Apr;18(2):120-441. (ID:ENSG00000196950)
4 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(D1):D991-5.
5 c-Jun binding site identification in K562 cells. J Genet Genomics. 2011;38(6):235-42.
6 Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma. Cancer Res. 2010;70(20):8199-210.
7 Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol Cell Biol. 2008;28(8):2732-44.
8 Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer. Mol Endocrinol. 2014;28(12):2012-24.
9 Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor. Oncotarget. 2012;3(2):183-94.
10 Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Res. 2011;71(20):6360-70.
11 Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening. PLoS One. 2014;9(4):e96184.
12 Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease. BMC Med. 2013;11:163.
13 Patterns of genome-wide VDR locations. PLoS One. 2014;9(4):e96105.
14 Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol Cell. 2009;36(4):667-81.
15 Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover. BMC Cancer. 2014;14:278.
16 Two major branches of anti-cadmium defense in the mouse: MTF-1/metallothioneins and glutathione. Nucleic Acids Res. 2005 Oct 12;33(18):5715-27.
17 SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin. Nucleic Acids Res. 2015;43(2):848-61.
18 The oncogenic MicroRNA Hsa-miR-155-5p targets the transcription factor ELK3 and links it to the hypoxia response. PLoS One. 2014;9(11):e113050.
19 Modulation of gene expression regulated by the transcription factor NF-B/RelA. J Biol Chem. 2014;289(17):11927-11944.
20 Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma. Neuro Oncol. 2013;15(3):279-89.
21 p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model. PLoS One. 2013;8(5):e62547.
22 Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation. Nucleic Acids Res. 2012;40(15):7190-206.
23 Genome-wide Runx2 occupancy in prostate cancer cells suggests a role in regulating secretion. Nucleic Acids Res. 2012;40(8):3538-47.
24 ChIP-seq defined genome-wide map of TGF/SMAD4 targets: implications with clinical outcome of ovarian cancer. PLoS One. 2011;6(7):e22606.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.